LeMaitre Vascular - 13 Year Stock Price History | LMAT

Historical daily share price chart and data for LeMaitre Vascular since 2006 adjusted for splits. The latest closing stock price for LeMaitre Vascular as of July 22, 2019 is 31.53.
  • The all-time high LeMaitre Vascular stock price is 40.76, which is 29.3% above the current share price.
  • The LeMaitre Vascular 52-week high stock price is 38.64, which is 22.5% above the current share price.
  • The LeMaitre Vascular 52-week low stock price is 22.01, which is 30.2% below the current share price.
  • The average LeMaitre Vascular stock price for the last 52 weeks is 29.00.
LeMaitre Vascular Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 27.4427 23.3900 31.5500 22.4500 31.5300 33.38%
2018 33.2265 30.8601 40.7554 22.0100 23.6400 -25.13%
2017 29.8374 24.8358 38.7418 21.5578 31.5741 26.58%
2016 16.9929 15.4057 25.0622 12.1726 24.9441 48.49%
2015 10.9354 7.5054 17.3046 6.9968 16.7982 128.79%
2014 7.2263 7.5382 7.9755 6.3032 7.3423 -2.72%
2013 6.2988 5.3318 8.1212 5.3318 7.5476 42.05%
2012 5.4151 5.2221 6.0168 4.5696 5.3133 -1.35%
2011 5.9788 6.2355 6.7779 4.8036 5.3858 -11.46%
2010 5.1618 4.4745 6.5410 3.9713 6.0827 35.40%
2009 2.9502 1.9228 4.4924 1.7161 4.4924 116.64%
2008 3.2174 5.3909 6.0288 1.6712 2.0737 -62.77%
2007 5.8234 5.4358 6.8734 4.9956 5.5706 3.33%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.598B $0.106B
LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects the people worldwide. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing, specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $154.348B 29.07
Medtronic (MDT) Ireland $135.189B 19.31
Stryker (SYK) United States $77.613B 27.70
Boston Scientific (BSX) United States $58.755B 28.17
Baxter (BAX) United States $42.395B 26.72
EssilorLuxottica Societe Anonyme (ESLOY) France $29.186B 0.00
Coloplast (CLPBY) Denmark $25.855B 41.28
Lonza Group Ag (LZAGY) Switzerland $25.565B 0.00
Zimmer Biomet Holdings (ZBH) United States $25.282B 16.24
Terumo (TRUMY) Japan $22.330B 25.68
Smith & Nephew SNATS (SNN) United Kingdom $18.881B 0.00
ResMed (RMD) United States $17.703B 33.83
Sunny Optical Technology (SNPTF) China $12.345B 0.00
Canopy Growth (CGC) Canada $12.272B 0.00
Bio-Rad Laboratories (BIO) United States $9.392B 49.79
William Demant Holdings (WILYY) Denmark $7.263B 0.00
Insulet (PODD) United States $7.231B 526.83
Hill-Rom Holdings (HRC) United States $7.018B 21.27
Perrigo (PRGO) Ireland $7.012B 11.85
Aurora Cannabis (ACB) Canada $6.936B 68.40
GN STORE NORD (GNNDY) Denmark $6.409B 32.73
Haemonetics (HAE) United States $6.251B 51.03
ICU Medical (ICUI) United States $5.188B 30.95
GW Pharmaceuticals (GWPH) United Kingdom $4.991B 0.00
Neogen (NEOG) United States $3.334B 54.21
NuVasive (NUVA) United States $3.016B 24.63
Hutchison China MediTech (HCM) China $2.777B 0.00
Agios Pharmaceuticals (AGIO) United States $2.746B 0.00
National Vision Holdings (EYE) United States $2.480B 52.83
Quidel (QDEL) United States $2.268B 23.54
Aphria (APHA) $1.604B 0.00
Cardiovascular Systems (CSII) United States $1.544B 886.40
Phibro Animal Health (PAHC) United States $1.216B 18.22
AtriCure (ATRC) United States $1.203B 0.00
VAREX IMAGING (VREX) United States $1.174B 24.93
NanoString Technologies (NSTG) United States $1.114B 0.00
Lantheus Holdings (LNTH) United States $1.097B 29.13
PetIQ (PETQ) United States $1.015B 24.66
Quanterix (QTRX) United States $0.779B 0.00
Cerus (CERS) United States $0.761B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.750B 21.03
Omeros (OMER) United States $0.719B 0.00
MacroGenics (MGNX) United States $0.717B 0.00
TG Therapeutics (TGTX) United States $0.681B 0.00
OraSure Technologies (OSUR) United States $0.530B 24.40
Surmodics (SRDX) United States $0.527B 76.59
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.499B 0.00
Meridian Bioscience (VIVO) United States $0.492B 15.04
BioLife Solutions (BLFS) United States $0.330B 103.12
Utah Medical Products (UTMD) United States $0.321B 22.20
Vapotherm (VAPO) United States $0.320B 0.00
Zynex (ZYXI) United States $0.251B 25.77
Cytosorbents (CTSO) United States $0.242B 0.00
Bovie Medical (APYX) United States $0.214B 0.00
Chimerix (CMRX) United States $0.188B 0.00
Rockwell Medical (RMTI) United States $0.174B 0.00
United Health Products (UEEC) United States $0.170B 0.00
Owens & Minor (OMI) United States $0.166B 3.52
Fonar (FONR) United States $0.142B 7.49
Female Health (VERU) United States $0.134B 0.00
Chembio Diagnostics (CEMI) United States $0.103B 0.00
United-Guardian (UG) United States $0.092B 20.16
Surface Oncology (SURF) United States $0.076B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.067B 0.00
Trinity Biotech (TRIB) Ireland $0.053B 18.33
ImmuCell (ICCC) United States $0.044B 0.00
Senestech (SNES) United States $0.038B 0.00
GUARDION HEALTH (GHSI) United States $0.037B 0.00
Capricor Therapeutics (CAPR) United States $0.020B 0.00
Valeritas Holdings (VLRX) United States $0.014B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.011B 0.00
Akers Biosciences Inc (AKER) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00